Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

0.34USD
3:01pm GMT
Change (% chg)

$0.00 (+1.26%)
Prev Close
$0.34
Open
$0.34
Day's High
$0.34
Day's Low
$0.34
Volume
48,672
Avg. Vol
285,631
52-wk High
$3.08
52-wk Low
$0.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 14 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.67 2.67 2.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2 1.58 1.70 1.46 51.50
Quarter Ending Mar-19 1 1.12 1.12 1.12 --
Year Ending Dec-18 2 9.20 9.20 9.20 18.01
Year Ending Dec-19 2 4.80 5.10 4.50 59.21
Earnings (per share)
Quarter Ending Dec-18 2 -0.09 -0.07 -0.12 0.06
Quarter Ending Mar-19 1 -0.15 -0.15 -0.15 --
Year Ending Dec-18 2 -0.98 -0.96 -1.00 -0.90
Year Ending Dec-19 2 -0.47 -0.40 -0.55 -0.71

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 1.89 0.94 0.95 50.21
Quarter Ending Jun-18 2.30 2.76 0.47 20.30
Quarter Ending Mar-18 2.31 4.07 1.76 76.30
Quarter Ending Dec-17 1.34 3.46 2.11 157.05
Quarter Ending Sep-17 1.09 3.92 2.83 259.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1.58 1.75 2.10 2.10 51.50
Quarter Ending Mar-19 1.12 1.25 1.25 -- --
Year Ending Dec-18 9.20 10.45 11.10 11.11 18.01
Year Ending Dec-19 4.80 5.05 6.83 6.83 59.21

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 0 1
Quarter Ending Mar-19 0 1 0 1
Year Ending Dec-18 0 2 0 2
Year Ending Dec-19 0 1 0 1
Earnings